More than half of South Koreans experience chronic resentment: survey
A recent survey found that more than half of South Koreans are in a state of prolonged resentment, with nearly 70 percent of respondents answering that they believed the world was unfair.
According to a survey conducted by Seoul National University's Graduate School of Public Health, 54.9 percent of the respondents were found to be in a state of chronic resentment, with the 12.8 percent of respondents indicating a level that was severe.
Among age groups, the highest proportion of those experiencing severe, prolonged resentment were found among those in their 30s at 17.4 percent, while the lowest proportion was found among individuals aged 60 and up at 9.5 percent.
Those who identified themselves as belonging to the lower social class had the highest level of severe resentment at 16.5 percent, but even among the upper class, 15 percent reported feeling high resentment. Those in the middle class had a relatively lower rate at 9.2 percent.
Perceptions of fairness were generally negative in the survey, with 69.5 percent of respondents disagreeing with the statement: The world is fundamentally fair.
According to the research team, levels of resentment were correlated with a belief that the world was unfair. The lower the level of belief that society was fair, the higher the level of resentment.
Groups that were more likely to see the world as unfair showed higher levels of resentment than those that were less likely to do so.
The research team added that the issues that most provoked feelings of resentment included: government coverups and corruption, unethical behavior by political parties and disasters caused by poor safety oversight.
Nearly half of the respondents — 47.1 percent — stated that they experienced severe stress in the past year that affected their health. People in their 40s at 55.4 percent and 30s at 51.7 percent, as well as those earning less than 2 million won ($1,429) per month at 53.8 percent, were found to be particularly vulnerable.
Major sources of stress for such respondents included personal or family health struggles, shifts in social relationships and changes in the political climate.
However, despite such widespread stress levels, many said that they found it difficult to seek professional help, as some 56 percent of respondents said that they 'would not seek support due to fear of stigma or prejudice.'
'Such findings show that the mental health of Koreans is troubling and that Korean society needs to take mental health more seriously,' said Lee Yoon-kyoung, a researcher from SNU's research team. 'There needs to be more practical and realistic improvements in mental health prevention and management programs.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
2 hours ago
- Korea Herald
Daewoong partners with Sweden's Salipro to boost drug discovery
Daewoong Pharmaceutical on Wednesday announced a strategic research partnership with Swedish biotech company Salipro Biotech to jointly develop next-generation therapeutics targeting membrane proteins. Under the agreement, Salipro will provide Daewoong access to its proprietary Salipro Platform, a technology that stabilizes membrane proteins in a near-native environment, making them more accessible for drug discovery. Membrane proteins are involved in essential cellular functions and account for over 60 percent of known drug targets, yet their structural instability in lab conditions has long been a barrier to research. The partnership is Salipro's first with a Korean company and follows previous collaborations with major pharmaceutical firms including Boehringer Ingelheim, Sanofi and Sumitomo. Daewoong views the alliance as a key step in its open innovation strategy, aiming to bolster its global competitiveness and lay the groundwork for potential overseas licensing deals. 'Our partnership with Daewoong marks Salipro's first collaboration with a Korean company, making it especially meaningful,' Jens Frauenfeld, CEO of Salipro Biotech, stated. 'The Salipro platform enables research on previously inaccessible target proteins and is expected to unlock new possibilities in global innovative drug development.' Park Seong-soo, CEO of Daewoong Pharmaceutical, added, 'We expect that the Salipro platform will enhance our access to challenging membrane protein targets and accelerate our drug discovery efforts. Through an open collaboration strategy, we will continue to develop globally competitive new drugs.'
Korea Herald
2 days ago
- Korea Herald
CGBio launches China joint venture to expand regenerative medicine reach
Korean regenerative medicine company CGBio, affiliated with Daewoong Pharmaceutical, announced Monday the establishment of Sol Cent Bio Co. Ltd., a joint venture with Chinese orthopedic device maker Shanghai Sanyou Medical, marking its full-scale entry into the Chinese regenerative medicine market. The new company will localize the production of advanced regenerative products and medical devices, including human tissue grafts and stem cell isolation systems, to meet China's growing clinical demand. Shanghai Sanyou Medical, a publicly listed company specializing in spinal and trauma care devices, brings strong manufacturing capabilities and a nationwide hospital network to the partnership. By combining CGBio's proprietary technologies with Sanyou's local expertise, Sol Cent Bio aims to accelerate regulatory approvals and build a stable supply chain within China. Initial offerings will include allogeneic bone grafts and acellular dermal matrices, widely used in bone regeneration, burn care and reconstructive surgery. The venture will also produce stem cell separation systems and other regenerative tools developed by CGBio and its subsidiary, CGMedtech. Through the joint venture, CGBio aims to expand its global footprint and deliver regenerative solutions tailored to Chinese patients and providers, while improving cost competitiveness under China's volume-based procurement system. 'The joint venture with Sanyou Medical marks a strategic shift, combining our technology with local manufacturing and sales strength,' said CGBio CEO Yu Hyun-seung. 'Local production will enhance supply stability and responsiveness, setting a new standard in Asia's regenerative medicine market.'
Korea Herald
2 days ago
- Korea Herald
South Korea weighs conditional licenses for drivers with dementia
South Korean authorities are weighing a proposal that would allow drivers with medical conditions, including dementia, to keep their licenses, but with certain restrictions, such as avoiding nighttime or highway driving. The plan is outlined in a report commissioned by the National Police Agency and conducted by researchers at Seoul National University. The agency said it is reviewing the recommendations, and that no final decisions have been made. Among the key proposals is the creation of a third-party reporting system that would allow family members, doctors or police officers to request immediate driving aptitude tests for individuals suspected of being unable to drive safely. 'It is necessary to pursue legislation that allows third parties, such as immediate family members or police officers, to request an aptitude test if a driver is suspected of being unfit to drive,' the report stated. The goal, researchers said, is to improve road safety through earlier intervention. Under current law, South Koreans with dementia may lose their licenses if they fail a driving aptitude test. But the test is administered only to those who apply for long-term care under the national insurance system. Those who do not apply can continue driving without being evaluated. That loophole prompted a public outcry last year after a man in his 70s with early-stage dementia caused a traffic accident in Seoul. He had not applied for long-term care status and therefore had not undergone the required screening. Critics also point out that even when drivers are in the system, the license revocation process can take up to 10 months, leaving a prolonged period during which at-risk individuals may continue driving. Roughly 970,000 South Koreans aged 65 and older -- which is about 9.2 percent of that age group -- are living with dementia, according to a March report from the Ministry of Health and Welfare. The proposal also recommends expanding eligibility for driving aptitude tests to include those with physical health conditions, such as heart disease and sleep disorders.
